pharma · Epilepsy · Attention-Deficit/Hyperactivity Disorder (ADHD) · SUPN
SUPERNUS PHARMACEUTICALS
SUPERNUS PHARMACEUTICALS, INC.
SUPERNUS PHARMACEUTICALS patent portfolio — 68 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 9715 Key West Ave, Rockville, Maryland 20850, US
- Founded
- 2005
- Employees
- 828
- Programs
- 55
- Drugs
- 25
- Patents
- 68
SUPERNUS PHARMACEUTICALS patents
68 pharmaceutical patents indexed for SUPERNUS PHARMACEUTICALS. 1 expire within 24 months.
SUPERNUS PHARMACEUTICALS has 68 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 8470364
Once daily formulations of tetracyclines
granted -
US 8394406
Once daily formulations of tetracyclines
granted -
US 8394405
Once daily formulations of tetracyclines
granted -
US 8298580
Sustained-release formulations of topiramate
granted -
US 8298576
Sustained-release formulations of topiramate
granted -
US 8211464
Modified release preparations containing oxcarbazepine and derivatives thereof
granted -
US 8206740
Once daily formulations of tetracyclines
granted -
US 8193211
Controlled release compositions of gamma-hydroxybutyrate
granted -
US 8017149
Modified release preparations containing oxcarbazepine and derivatives thereof
granted -
US 7910128
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
granted -
US 7910131
Method of treating seizures using modified release formulations of oxcarbazepine
granted -
US 7781448
Once daily dosage forms of trospium
granted -
US 7781449
Trospium chloride treatment method
granted -
US 7763635
Once daily dosage forms of trospium
granted -
US 7759359
Method of treating bladder dysfunction with once-a-day trospium salt formulation
granted -
US 7749532
Once daily formulations of tetracyclines
granted -
US 7722898
Modified-release preparations containing oxcarbazepine and derivatives thereof
granted -
US 7611728
Osmotic delivery of therapeutic compounds by solubility enhancement
granted -
US 7410978
Once daily dosage forms of trospium
granted -
US 7259153
Drug formulation and delivery using crystalline methylated cyclodextrins
granted
Frequently asked questions
How many patents does SUPERNUS PHARMACEUTICALS have?
68 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do SUPERNUS PHARMACEUTICALS patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.